1 Introduction to Research & Analysis Reports 1.1 Cerebrovascular Disease Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Cerebrovascular Disease Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Cerebrovascular Disease Overall Market Size 2.1 United States Cerebrovascular Disease Market Size: 2021 VS 2027 2.2 United States Cerebrovascular Disease Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Cerebrovascular Disease Players in United States Market 3.2 Top United States Cerebrovascular Disease Companies Ranked by Revenue 3.3 United States Cerebrovascular Disease Revenue by Companies 3.4 Top 3 and Top 5 Cerebrovascular Disease Companies in United States Market, by Revenue in 2020 3.5 Companies Cerebrovascular Disease Product Type 3.6 Tier 1, Tier 2 and Tier 3 Cerebrovascular Disease Players in United States Market 3.6.1 List of Tier 1 Cerebrovascular Disease Companies in United States 3.6.2 List of Tier 2 and Tier 3 Cerebrovascular Disease Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Cerebrovascular Disease Market Size Markets, 2021 & 2027 4.1.2 Carotid Endarterectomy 4.1.3 Carotid Angioplasty Or Carotid Artery Stenting 4.1.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) 4.2 By Type - United States Cerebrovascular Disease Revenue & Forecasts 4.2.1 By Type - United States Cerebrovascular Disease Revenue, 2016-2021 4.2.2 By Type - United States Cerebrovascular Disease Revenue, 2022-2027 4.2.3 By Type - United States Cerebrovascular Disease Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Cerebrovascular Disease Market Size, 2021 & 2027 5.1.2 Academic & Research Institutes 5.1.3 Pharmaceutical & Biotechnology Companies 5.1.4 Hospitals & Diagnostic Centers 5.1.5 Contract Research Organizations 5.1.6 Others 5.2 By Application - United States Cerebrovascular Disease Revenue & Forecasts 5.2.1 By Application - United States Cerebrovascular Disease Revenue, 2016-2021 5.2.2 By Application - United States Cerebrovascular Disease Revenue, 2022-2027 5.2.3 By Application - United States Cerebrovascular Disease Revenue Market Share, 2016-2027 6 Cerebrovascular Disease Companies Profiles 6.1 Johnson & Johnson 6.1.1 Johnson & Johnson Company Details 6.1.2 Johnson & Johnson Business Overview 6.1.3 Johnson & Johnson Cerebrovascular Disease Introduction 6.1.4 Johnson & Johnson Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.1.5 Johnson & Johnson Recent Developments 6.2 Amgen 6.2.1 Amgen Company Details 6.2.2 Amgen Business Overview 6.2.3 Amgen Cerebrovascular Disease Introduction 6.2.4 Amgen Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.2.5 Amgen Recent Developments 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Company Details 6.3.2 GlaxoSmithKline Business Overview 6.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction 6.3.4 GlaxoSmithKline Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.3.5 GlaxoSmithKline Recent Developments 6.4 Sanofi-Aventis 6.4.1 Sanofi-Aventis Company Details 6.4.2 Sanofi-Aventis Business Overview 6.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction 6.4.4 Sanofi-Aventis Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.4.5 Sanofi-Aventis Recent Developments 6.5 Merck 6.5.1 Merck Company Details 6.5.2 Merck Business Overview 6.5.3 Merck Cerebrovascular Disease Introduction 6.5.4 Merck Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.5.5 Merck Recent Developments 6.6 Sangamo BioSciences 6.6.1 Sangamo BioSciences Company Details 6.6.2 Sangamo BioSciences Business Overview 6.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction 6.6.4 Sangamo BioSciences Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.6.5 Sangamo BioSciences Recent Developments 6.7 Aldagen 6.7.1 Aldagen Company Details 6.7.2 Aldagen Business Overview 6.7.3 Aldagen Cerebrovascular Disease Introduction 6.7.4 Aldagen Cerebrovascular Disease Revenue in United States Market (2016-2021) 6.7.5 Aldagen Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Cerebrovascular Disease Market Opportunities & Trends in United States Market Table 2. Cerebrovascular Disease Market Drivers in United States Market Table 3. Cerebrovascular Disease Market Restraints in United States Market Table 4. Key Players of Cerebrovascular Disease in United States Market Table 5. Top Cerebrovascular Disease Players in United States Market, Ranking by Revenue (2019) Table 6. United States Cerebrovascular Disease Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Cerebrovascular Disease Revenue Share by Companies, 2016-2021 Table 8. Companies Cerebrovascular Disease Product Type Table 9. List of Tier 1 Cerebrovascular Disease Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Cerebrovascular Disease Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Cerebrovascular Disease Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Cerebrovascular Disease Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Cerebrovascular Disease Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Cerebrovascular Disease Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Cerebrovascular Disease Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Cerebrovascular Disease Revenue (US$, Mn), 2022-2027 Table 17. Johnson & Johnson Company Details Table 18. Johnson & Johnson Business Overview Table 19. Johnson & Johnson Cerebrovascular Disease Product Table 20. Johnson & Johnson Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Johnson & Johnson Recent Developments Table 22. Amgen Company Details Table 23. Amgen Business Overview Table 24. Amgen Cerebrovascular Disease Product Table 25. Amgen Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Amgen Recent Developments Table 27. GlaxoSmithKline Company Details Table 28. GlaxoSmithKline Business Overview Table 29. GlaxoSmithKline Cerebrovascular Disease Product Table 30. GlaxoSmithKline Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 31. GlaxoSmithKline Recent Developments Table 32. Sanofi-Aventis Company Details Table 33. Sanofi-Aventis Business Overview Table 34. Sanofi-Aventis Cerebrovascular Disease Product Table 35. Sanofi-Aventis Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Sanofi-Aventis Recent Developments Table 37. Merck Company Details Table 38. Merck Business Overview Table 39. Merck Cerebrovascular Disease Product Table 40. Merck Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Merck Recent Developments Table 42. Sangamo BioSciences Company Details Table 43. Sangamo BioSciences Business Overview Table 44. Sangamo BioSciences Cerebrovascular Disease Product Table 45. Sangamo BioSciences Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Sangamo BioSciences Recent Developments Table 47. Aldagen Company Details Table 48. Aldagen Business Overview Table 49. Aldagen Cerebrovascular Disease Product Table 50. Aldagen Cerebrovascular Disease Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Aldagen Recent Developments List of Figures Figure 1. Cerebrovascular Disease Segment by Type Figure 2. Cerebrovascular Disease Segment by Application Figure 3. United States Cerebrovascular Disease Market Overview: 2020 Figure 4. United States Cerebrovascular Disease Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Cerebrovascular Disease Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2020 Figure 7. By Type - United States Cerebrovascular Disease Revenue Market Share, 2016-2027 Figure 8. By Application - United States Cerebrovascular Disease Revenue Market Share, 2016-2027 Figure 9. Johnson & Johnson Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Amgen Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. GlaxoSmithKline Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Sanofi-Aventis Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Merck Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Sangamo BioSciences Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Aldagen Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Johnson & Johnson Amgen GlaxoSmithKline Sanofi-Aventis Merck Sangamo BioSciences Aldagen